Evidence map›Paper›PMID 30215671›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Increased Metabolic Activity on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Human Immunodeficiency Virus-Associated Immune Reconstitution Inflammatory Syndrome.

Dima A Hammoud, Afroditi Boulougoura, Georgios Z Papadakis, Jing Wang, Lori E Dodd, Adam Rupert, Jeanette Higgins, Gregg Roby, Dorinda Metzger, Elizabeth Laidlaw and 9 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02147405 (PET Imaging and Lymph Node Assessment of IRIS in Persons With AIDS), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02147405 recruitingnot on this map

PET Imaging and Lymph Node Assessment of IRIS in Persons With AIDS

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2014 to 2030Enrolled300ConditionsImmune Reconstitution Inflammatory Syndrome
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Nuclear medicine and molecular imaging · 2025
    Article
  3. When Location and Timing Are at the Heart of the Diagnosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. DoesFrontiers in medicine · 2022
    Article
  9. Article
  10. Article
  11. State of the art ofClinical and translational imaging · 2021
    Review
  12. Review
  13. Observational
  14. Article
  15. Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  16. PET/CT and PET/MRI in ophthalmic oncology (Review).International journal of oncology · 2020
    Review
  17. Article
  18. Review
  19. Management of Advanced HIV Disease.Infectious disease clinics of North America · 2019
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Dima A HammoudCenter for Infectious Diseases Imaging, Clinical Center, National Institutes of Health (NIH).
Afroditi BoulougouraDivision of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda.
Georgios Z PapadakisCenter for Infectious Diseases Imaging, Clinical Center, National Institutes of Health (NIH).
Jing WangClinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc, National Cancer Institute, Frederick.
Lori E DoddBiostatistics Research Branch, NIAID, NIH, Bethesda.
Adam RupertLeidos Biomedical Research Inc, Frederick National Laboratory for Cancer Research.
Jeanette HigginsLeidos Biomedical Research Inc, Frederick National Laboratory for Cancer Research.
Gregg RobyDivision of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda.
Dorinda MetzgerDivision of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda.
Elizabeth LaidlawDivision of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda.
JoAnn M MicanDivision of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda.
Alice PauDivision of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda.
Silvia LageDivision of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda.
Chun-Shu WongDivision of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda.
Andrea LiscoDivision of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda.
Maura ManionDivision of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda.
Virginia SheikhDivision of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda.
Corina MilloPositron Emission Tomography Department, Clinical Center, NIH, Bethesda, Maryland.
Irini SeretiDivision of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda.
National Institute of Allergy and Infectious Diseases · USLeidos (United States) · USNational Institutes of Health · USPositron (United States) · US

Funding

Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) DiseaseZIAAI001121 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SERETI, IRINI · 2010 to 2025
$27.2M
PET imaging of presynaptic nigrostriatal dopaminergic function in optimally treated HIV+ patientsZIACL010357 · CLC · CLINICAL CENTER · PI HAMMOUD, DIMA A · 2017 to 2024
$0k
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

Background: Immune reconstitution inflammatory syndrome (IRIS) represents an unexpected inflammatory response shortly after initiation of antiretroviral therapy (ART) in some human immunodeficiency virus (HIV)-infected patients with underlying neoplasia or opportunistic infections, including tuberculosis. We hypothesized that IRIS is associated with increased glycolysis and that 18F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) could help identify high-risk subjects. Methods: In this prospective cohort study, 30 HIV-infected patients (CD4+ count <100 cells/µL) underwent FDG-PET/CT scans at baseline and 4-8 weeks after ART initiation. Ten patients developed IRIS (6 mycobacterial). Results: At baseline, total glycolytic activity, total lesion volume, and maximum standardized uptake values (SUVs) of pathologic FDG uptake (reflective of opportunistic disease burden) were significantly higher in IRIS vs non-IRIS (P = .010, .017, and .029, respectively) and significantly correlated with soluble inflammatory biomarkers (interferon-γ, myeloperoxidase, tumor necrosis factor, interleukin 6, soluble CD14). Baseline bone marrow (BM) and spleen FDG uptake was higher in mycobacterial IRIS specifically. After ART initiation, BM and spleen mean SUV decreased in non-IRIS (P = .004, .013) but not IRIS subjects. Our results were supported by significantly higher glucose transporter 1 (Glut-1) expression of CD4+ cells and monocytes after ART initiation in IRIS/mycobacterial IRIS compared with non-IRIS patients. Conclusions: We conclude that increased pathologic metabolic activity on FDG-PET/CT prior to ART initiation is associated with IRIS development and correlates with inflammatory biomarkers. Abnormally elevated BM and spleen metabolism is associated with mycobacterial IRIS, HIV viremia, and Glut-1 expression on CD4+ cells and monocytes. Clinical Trials Registration: NCT02147405.

Indexed as

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyAdultAnti-HIV AgentsBiomarkersFemaleGene Expression RegulationGlucose Transporter Type 1HIV InfectionsHumansImmune Reconstitution Inflammatory SyndromeMaleMonocytesRadiopharmaceuticalsT-LymphocytesAnti-HIV AgentsBiomarkersFluorodeoxyglucose F18Glucose Transporter Type 1Radiopharmaceuticals

Identifiers

PMID30215671
PMCPMC6321853
OpenAlexW2891693365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.